Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average): 2012-2015

Historic Shares Outstanding (Diluted Average) for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Dec 2015 value amounting to $45.0 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) rose 2.50% to $46.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.0 million, marking a year-over-year increase of 2.50%. This contributed to the annual value of $45.0 million for FY2015, which is 7.16% up from last year.
  • According to the latest figures from FY2015, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) is $45.0 million, which was up 7.16% from $42.0 million recorded in FY2014.
  • Amphastar Pharmaceuticals' 5-year Shares Outstanding (Diluted Average) high stood at $45.0 million for FY2015, and its period low was $38.9 million during FY2013.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $42.0 million (recorded in 2014), while the average stood at $41.9 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first dropped by 0.15% in 2013, then grew by 7.91% in 2014.
  • Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $38.9 million in 2012, then dropped by 0.15% to $38.9 million in 2013, then rose by 7.91% to $42.0 million in 2014, then increased by 7.16% to $45.0 million in 2015.